Cancer after exposure to radiation in the course of treatment for benign and malignant disease

Lancet Oncology

Volumn 2, Issue 4, 2001, Pages 212-220

  Little, Mark P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; JAPAN; LIFESTYLE; NEOPLASM; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK FACTOR; SMOKING; SURVIVOR; UNITED STATES; WAR;

HUMANS; JAPAN; LIFE STYLE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RISK FACTORS; SMOKING; SURVIVORS; UNITED STATES; WAR;

EID: 0035323382     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00291-6     Document Type: Review

References (56)

1. Curtis R.E., Boice J.D., Kleinerman R.A., et al. Summary: multiple primary cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr. 68:1985;219-242.
2. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR report to the General Assembly, with scientific annexes. Volume I: sources. New York: United Nations, 2000.
3. Weiss H.A., Darby S.C., Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer. 59:1994;327-338.
4. Darby S.C., Reeves G., Key T., et al. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer. 56:1994;793-801.
5. Lundell M., Hakulinen T., Holm L.-E. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res. 140:1994;334-339.
6. Karlsson P., Holmberg E., Lundell M., et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28 008 infants with skin hemangioma. Radiat Res. 150:1998;357-364.
7. Lundell M., Mattsson A., Karlsson P., Holmberg E., Gustafsson A., Holm L.-E. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17 202 infants. Radiat Res. 151:1999;626-632.
8. International Commission on Radiological Protection (ICRP). Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991; 21: 1-3. Oxford: Pergamon, Publication 60.
9. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radiation. UNSCEAR report to the General Assembly, with scientific annexes. Volume II: Effects. New York: United Nations, 2000.
10. Stovall M., Smith S.A., Rosenstein M. Tissue doses from radiotherapy of cancer of the uterine cervix. Med Phys. 16:1989;726-733.
11. Cosset J.-M. Radium in medicine. Radiol Prot Bull. 205:1998;11-14.
12. World Health Organization. Radiotherapy in cancer management. A practical manual. London: Chapman and Hall, 1997.
13. Diallo I., Lamon A., Shamsaldin A., et al. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol. 38:1996;269-271.
14. Savitsky K., Bar-Shira A., Gilad S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
15. Ross G.M., Eady J.J., Mithal N.P., et al. DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene. Cancer Res. 55:1995;1235-1238.
16. Tambini C.E., George A.M., Rommens J.M., et al. The XRCC2 DNA repair gene: identification of a positional candidate. Genomics. 41:1997;84-92.
17. International Commission on Radiological Protection (ICRP). Genetic susceptibility to cancer. Ann ICRP 1999; 28: 1-2. Oxford: Pergamon, Publication 79.
18. Goodhead D.T. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol. 65:1994;7-17.
19. Renan M.J. How many mutations are required for tumorigenesis? Implications from human cancer data. Molec Carcinogenesis. 7:1993;139-146.
20. Little M.P. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics. 51:1995;1278-1291.
21. Epstein R., Hanham I., Dale R. Radiotherapy-induced second cancers: are we doing enough to protect young patients? Eur J Cancer. 33:1997;526-530.
22. Inskip P.D., Stovall M., Flannery J.T. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst. 86:1994;983-988.
23. Tucker M.A., Jones P.H., Boice J.D., et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res. 51:1991;2885-2888.
24. Boice J.D., Engholm G., Kleinerman R.A., et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res. 116:1988;3-55.
25. Tucker M.A., D'Angio G.J., Boice J.D., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 317:1987;588-593.
26. Little J.B., Nagasawa H., Pfenning T., Vetrovs H. Radiation-induced genomic instability: delayed mutagenic and cytogenetic effects of X rays and alpha particles. Radiat Res. 148:1997;299-307.
27. Ames B.N., Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 249:1990;970-971.
28. Little M.P. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. Int J Radiat Biol. 77:2001;431-464.
29. Little M.P., Muirhead C.R., Haylock R.G.E., Thomas J.M. Relative risks of radiation-associated cancer: comparison of second cancer in therapeutically irradiated populations with the Japanese atomic bomb survivors. Radiat Environ Biophys. 38:1999;267-283.
30. Deschavanne P.J., Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys. 34:1996;251-266.
31. Preston D.L., Kusumi S., Tomonaga M., et al. Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 137:1994;S68-S97.
32. Boice J.D., Blettner M., Kleinerman R.A., et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst. 79:1987;1295-1311.
33. Little M.P., Weiss H.A., Boice J.D., et al. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res. 152:1999;280-292.
34. Pierce D.A., Shimizu Y., Preston D.L., et al. Studies of the mortality of atomic bomb survivors 1950-1990. Report 12, part I. Cancer: 1950-1990. Radiat Res. 146:1996;1-27.
35. Brenner D.J., Hall E.J. The inverse dose-rate effect for oncogenic transformation by neutrons and charged particles: a plausible interpretation consistent with published data. Int J Radiat Biol. 58:1990;745-758.
36. World Health Organization. World health statistics annual 1989. Geneva: WHO, 1989.
37. Parkin D.M., Whelan S.L., Ferlay J., et al. Cancer incidence in five continents volume VII (IARC Scientific Publications Number 143). 1997;Lyon, IARC.
38. Storm H.H., Iversen E., Boice J.D. Breast cancer following multiple chest fluoroscopies among tuberculosis patients. A case-control study in Denmark. Acta Radiologica Oncol. 25:1986;233-238.
39. Preston-Martin S., Thomas D.C., White S.C., Cohen D. Prior exposure to medical and dental X-rays related to tumors of the parotid gland. J Natl Cancer Inst. 80:1988;943-949.
40. Davis F.G., Boice J.D., Hrubec Z., Monson R.R. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49:1989;6130-6136.
41. Andersson M., Storm H.H. Cancer incidence among Danish Thorotrast-exposed patients. J Natl Cancer Inst. 84:1992;1318-1325.
42. Hall P., Boice J.D., Berg G., et al. Leukaemia incidence after iodine-131 exposure. Lancet. 340:1992;1-4.
43. Howe G.R. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res. 142:1995;295-304.
44. Hall P., Mattsson A., Boice J.D. Thyroid cancer after diagnostic administration of iodine-131. Radiat Res. 145:1996;86-92.
45. Howe G.R., McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res. 145:1996;694-707.
46. Little M.P., Boice J.D. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res. 151:1999;218-224.
47. Doody M.M., Lonstein J.E., Stovall M., et al. Breast cancer mortality after diagnostic radiography. Findings from the US scoliosis cohort study. Spine. 25:2000;2052-2063.
48. Kaldor J.M., Day N.E., Bell J., et al. Lung cancer following Hodgkin's disease: a controlled study. Int J Cancer. 52:1992;677-681.
49. Little M.P., de Vathaire F., Shamsaldin A., et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer. 78:1998;269-275.
50. Curtis R.E., Boice J.D., Stovall M., et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med. 326:1992;1745-1751.
51. van Leeuwen F.E., Klokman W.J., Stovall M., et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst. 87:1995;1530-1537.
52. Kopecky KJ, Nakashima E, Yamamoto T, Kato H. Lung cancer, radiation, and smoking among A-bomb survivors, Hiroshima and Nagasaki. RERF Technical Report TR 13-86. Hiroshima: Radiation Effects Research Foundation, 1988.
53. US National Academy of Sciences, Committee on Health Risks of Exposure to Radon (BEIR VI). Health effects of exposure to radon. Washington, DC: National Academy Press, 1999.
54. Wong F.L., Boice J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 278:1997;1262-1267.
55. Kony S.J., de Vathaire F., Chompret A., et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet. 350:1997;91-95.
56. Thompson D.E., Mabuchi K., Ron E., et al. Cancer incidence in atomic-bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 137:1994;S17-S67.